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eSchool of Public Health and Population Science, University College Dublin, Earlsfort Terrace, Dublin, IrelandAbstractObjective: To study the impact of dose parameters on image quality at whole-body low-dose multidetector computed tomography (CT) in an
attempt to derive parameters that allow diagnostic quality images of the skeletal system without incurring significant radiation dose in
patients referred for investigation of plasma cell dyscrasias.
Methods: By using a single cadaver, 14 different whole-body low-dose CT protocols were individually assessed by 2 radiologists, blinded to
acquisition parameters (kVp and mAs, reconstruction algorithm, dose reduction software). Combinations of kVps that range from 80-140 kVp,
and tube current time product from 14e125 mAs were individually scored by using a Likert scale from 1e5 in 4 separate anatomical areas
(skull base, thoracic spine, pelvis, and distal femora). Correlation between readers scores and effective doses were obtained by using
correlation coefficient statistical analysis, statistical significance was considered P < .01. Interobserver agreement was assessed by using
a Bland and Altman plot. Interobserver agreement in each of the 4 anatomical areas was assessed by using kappa statistics. A single set of
parameters was then selected for use in future clinical trials in a cohort of patients referred for investigation of monoclonal gammopathy,
including multiple myeloma.
Results: Several sets of exposure parameters allowed low-dose whole-body CT to be performed with effective doses similar to skeletal
survey while preserving diagnostic image quality. Individual reader’s and average combined scores showed a strong inverse correlation with
effective dose (reader 1, r ¼ e0.78, P ¼ .0001; reader 2, r ¼ e0.75, P ¼ .0003); average combined scores r ¼ e0.81, P < .0001). Bland and
Altman plot of overall scores shows reasonable interobserver agreement, with a mean difference of 1.055.
Conclusion: Whole-body low-dose CT can be used to obtain adequate CT image quality to assess normal osseous detail while delivering
effective doses similar to those associated with conventional radiographic skeletal survey.Re´sume´Objectif: E´valuer l’impact de modifications des parame`tres de dose sur la qualite´ de l’image re´sultant d’une tomodensitome´trie multibarette
pancorporelle a` faible dose, afin de de´terminer les parame`tres qui permettraient d’obtenir des images diagnostiques de qualite´ du squelette
sans utiliser de doses nocives de radiation, chez les patients devant subir des examens de de´tection de la dysglobuline´mie plasmocytaire.
Me´thodologie: A` partir d’un seul cadavre, 14 protocoles de tomodensitome´trie totale a` faible dose ont e´te´ e´value´s de fac¸on inde´pendante par
deux radiologues auxquels les parame`tres d’acquisition (kVp et mAs, algorithme de reconstruction et logiciel de re´duction de la dose) n’ont
pas e´te´ de´voile´s. Chaque radiologue a attribue´ un pointage aux combinaisons de kVp allant de 80 a` 140 kVp et de produits courant-temps
allant de 14 a` 125 mAs a` partir d’une e´chelle de Likert de 1 a` 5 pour quatre re´gions anatomiques (base du craˆne, colonne thoracique, pelvis et
fe´mur distal). La corre´lation entre les pointages attribue´s par les observateurs et les doses efficaces a e´te´ obtenue par analyse statistique du* Address for correspondence: Tadhg G. Gleeson, Department of Radiology and Diagnostic Imaging, Wexford General Hospital, Wexford, Ireland.
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259Dose optimization in whole body low dose CT / Canadian Association of Radiologists Journal 61 (2010) 258e264coefficient de corre´lation, ou` la signification statistique est P < .01. La concordance inter-observateur a e´te´ e´value´e au moyen de la
repre´sentation de Bland-Altman. Pour chacune des re´gions anatomiques, elle a e´te´ e´value´e au moyen des statistiques Kappa. Un ensemble
unique de parame`tres a par la suite e´te´ se´lectionne´ en vue d’une utilisation dans le cadre d’essais cliniques aupre`s d’une cohorte de patients
devant subir des examens de de´tection de la dysglobuline´mie plasmocytaire, y compris des cas de mye´lome multiple.
Re´sultats: Plusieurs ensembles de parame`tres d’exposition ont permis la re´alisation de tomodensitome´tries pancorporelles a` faible dose au
moyen de doses efficaces similaires a` celles utilise´es pour un examen radiographique du squelette tout en pre´servant la qualite´ de l’image
diagnostique. Les pointages attribue´s par chaque radiologue et le pointage moyen ont re´ve´le´ une forte corre´lation ne´gative avec la dose
efficace (observateur 1 : r ¼ e0,78, P ¼ 0,0001; observateur 2 : r ¼ e0,75, P ¼ 0,0003; pointage moyen : r ¼ e0,81, P < 0,0001). La
repre´sentation de Bland-Altman des pointages globaux te´moigne d’une concordance inter-observateur acceptable avec une diffe´rence
moyenne de 1,055.
Conclusion: La tomodensitome´trie pancorporelle a` faible dose permet d’obtenir une image de qualite´ diagnostique satisfaisante pour
l’e´valuation du squelette osseux, tout en limitant l’irradiation du sujet a` des doses similaires a` celles utilise´es pour l’examen radiographique
conventionnel du squelette.
 2010 Canadian Association of Radiologists. All rights reserved.
Key Words: Computed tomography; Dose; Multiple myelomaA radiographic survey of the skeleton is an essential part of
the workup of patients with plasma cell dyscrasias, in partic-
ular, multiple myeloma, the most common of the clinically
overt monoclonal gammopathies. International guidelines
currently recommend skeletal survey for assessment of
multiple myeloma at diagnosis and reserve newer modalities,
such as computed tomography (CT), magnetic resonance
imaging (MRI), and fluoro-deoxy-glucose positron emission
tomography (FDG-PET), for ambiguous cases [1]. Imaging
features of myeloma include focal lytic lesions in the axial and
appendicular skeleton, generalized osteopenia, or, rarely, focal
osteosclerosis [2]. The demonstration of radiographically
normal osseous structures can be useful in differentiating
myeloma from either the presymptomatic form of the disease
(smouldering myeloma) or from more benign etiologies, such
as monoclonal gammopathy of uncertain significance
(MGUS), or transient plasma cell dyscrasias associated with
drug hypersensitivity, viral infection, or cardiac surgery.
Similarly, recent advances in chemotherapy and radiation
therapy for myeloma have meant that accurate diagnosis and
anatomic staging (for example, the Durie-Salmon Plus staging
system [3]) of the disease has taken on increased significance.
Recent advances in multidetector CT technology have
provided the opportunity to use an imaging technique that is
more sensitive than the traditional criterion standard of
conventional radiographic skeletal survey [4]. However,
standard-dose whole-body CT can result in cumulative doses
of between 23.3e36.6 mSv being incurred by the patient [4],
and, given the increasing numbers of restaging examinations
and increased use of FDG-PET, the use of standard-dose
whole-body CT would result in a significant lifetime radia-
tion burden being incurred by this population group. Recent
articles highlighted radiologists ongoing concerns regarding
potential overexposure of patients to ionizing radiation [5]
and the potential, albeit controversial, reported increased
risk of radiation-induced cancer [6]. Thus, the use of stan-
dard CT of the whole body as a screening tool for MGUS or
its use as a regular restaging technique for multiple myeloma
could not be ethically justified.However, by using a low-dose technique, whole-body CT
was shown to be effective and accurate at staging myeloma
when compared with skeletal survey [7], as well as being
a reliable method for monitoring patients with myeloma,
having been shown to have good concordance with hema-
tologic parameters [8]. In the landmark study by Horger et al
[7], the low-dose CT parameters used were 120 kVp and
either 40, 50, 60, or 70 mAs, which results in effective doses
of approximately 4.1 mSv (40 mAs setting). However, the
reasons for using these imaging parameters were not out-
lined, and a detailed review of the literature that used
evidence-based medicine principles yielded no study that
addressed the optimization of a low-dose technique in
assessing the bony skeleton.
The use of cadaver specimens to assess low-dose tech-
niques was previously reported [9]. The aim of this study,
therefore, was to use a cadaveric model to achieve the lowest
possible dose with CT while maintaining image quality and
to assess the feasibility of using these low-dose techniques in
imaging normal osseous detail in the axial and appendicular
skeleton. In particular, it was essential that a much wider
range of mAs and kVp values than those previously
described be assessed in an attempt to establish the optimal
compromise between subjective image quality and patient
dose.
Methods
After approval from both university and hospital ethics
committees, a male cadaver of 178 cm height and weighing
98.2 kg was obtained from the university anatomy depart-
ment. By using protective coverings, the cadaver was imaged
by sequentially modified imaging parameters (Figure 1),
starting with the highest dose parameters as was used for CT
skeletal assessment in the clinical setting at our institution
(100 kVp, 80 mAs). Exposure parameters were modified by
varying kVp and mAs settings to produce a range of incre-
mentally reducing CT dose index volume (CTDIvol) values
(equated to dose length product values, because length of
Figure 1. Cadaver before scanning on multidetector computed tomography.
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3e18).
Effective dose (E) for each set of parameters was esti-
mated from the equation ‘‘dose length product ¼ CTDIvol 
length of scan’’ as recorded by the system. This was per-
formed by using ImpactDose software (2004; VAMP,
Erlangen, Germany), which allowed estimation of sex-
specific organs and patient effective doses based on Monte
Carlo computations of dose values in standardized phantoms.
The effects of automated tube current modulation (CARE
Dose; Siemens, Forchheim, Germany) was assessed at the
highest dose of exposure parameters, scans were scored both
with and without dose-reduction software enabled (Table 1,
nos. 1, 2, 17, and 18). These images were subsequently
reassessed, and an opinion in regard to any appreciable
deterioration in diagnostic quality because of dose reduction
software was reached by consensus.Table 1















1 140 14 14 1.43 185 Off 2.214
2 140 28 28 2.86 368 Off 4.427
3 140 21 17 1.73 223 On 2.688
4 140 35 28 2.86 369 On 4.427
5 100 80 66 2.95 381 On 4.447
6 100 20 16 0.72 93 On 1.078
7 100 40 31 1.40 180 On 2.090
8 100 60 49 2.21 285 On 3.303
9 120 17 14 0.94 122 On 1.514
10 120 34 27 1.86 240 On 2.921
11 120 26 21 1.43 186 On 2.272
12 120 50 40 2.80 362 On 4.331
13 80 25 19 0.42 55 On 0.681
14 80 50 39 0.86 112 On 1.267
15 80 100 83 1.83 239 On 2.696
16 80 125 98 2.16 283 On 3.183
17 140 14 11 1.12 147 On 1.740
18 140 28 23 2.29 301 On 3.636Imaging ParametersAll images were acquired on a Siemens SOMATOM
Sensation 16-slice multidetector CT. The cadaver was
imaged from skull vertex to mid tibia, with scan duration
averaging 15.32 seconds. Slices were acquired in 3.0-mm
sections by using 16  1.5-mm collimation and were
reconstructed into 3-mm slices. Four different reconstruction
algorithms were initially assessed at the initial highest setting
(100 kV, 80 mAs), which ranged from soft (B30f) to sharp
algorithms (B70f). These were assessed by 2 staff grade
radiologists (T.G. and S.E.), and optimal kernel for bony
assessment was chosen by consensus. Axial images were
reviewed (Figure 2), as well as multiplanar reformats (MPR)
in the sagittal and coronal planes (Figure 3) by using
a Leonardo workstation (Siemens).
All images for each set of parameters (Table 1) were
assessed by 2 experienced staff-grade radiologists, blinded to
effective dose and parameter values. Each data set was
scored individually from 1e5 by using a Likert scale (1, very
good image quality; 2, good image quality; 3, average and/or
diagnostic image quality; 4, sufficient for diagnosis but
suboptimal; and 5, poor and/or nondiagnostic) by assessing 4
separate anatomical areas: skull base, thoracic spine, pelvis,
and distal femora. Skull base was chosen because more
visible osseous matrix was identifiable on a single slice. In
addition, osseous detail in the region of the petrous temporal
bone allowed more-sensitive assessment of image quality
and easier comparison of different acquisitions. Thoracic
spine was assessed at a level that included the assessment of
adjacent ribs, scapulae, and proximal humeri. Conspicuity of
a vertebral body bone island at this level also allowed for
more accurate comparison (Figure 2B). The pelvis was
assessed at the S1 level because of the high volume of
osseous structures at this level as well as a focal enostosis in
the left ilium (Figure 2C). Trabecular detail in femoral
condyles as well as the presence of a small degenerative cyst
in the medial aspect of the left lateral femoral condyle was
thought to be useful for comparison.
The 4 anatomic regions were scored under headings
modified from Gurung et al [10]: trabecular pattern, cortical
contours, subjective image quality, subjective impression of
image noise, and level of anatomical detail, giving an overall
score out of 100. The overall average Likert score was then
calculated from these for each of the 16 different sets of
parameters and compared with the corresponding effective
dose. Average combined reader scores for each anatomical
area were also assessed (Table 2).Statistical AnalysisScores were tabulated, and overall interobserver agree-
ment was assessed by using a Bland and Altman plot.
Interobserver agreement in each of the anatomical areas
(skull, thoracic spine, pelvis, and femora) was assessed by
using kappa statistics, statistical significance was considered
P < .01 (Table 3). Individual reader scores and overall
Figure 2. Axial images at the chosen set of parameters of 140 kVp, 14 mAs at the level of (A) skull base, (B) thoracic spine, (C) pelvis, and (D) femora. Images
show anatomical detail of the petrous temporal bone and/or inner ear structures, and enostoses in the vertebral bodies and left iliac wing.
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overall combined reader Likert score (of 5) was calculated
for each set of parameters and tabulated against increasing
dose (Figure 4). Those parameters with diagnostic scores
(Likert score less than or equal to 3) and low effective dose
(left lower quadrant of the graph) were reexamined, and
a single data set was chosen by consensus as the optimum
parameter combination for use in a clinical setting.
Results
Regarding reconstruction algorithms, the moderately
sharp B60f kernel was thought to be superior for assessing
osseous structures, because cortical margins were sharply
outlined without excessive background noise (as seen on the
very sharp algorithm B70f). Both reader 1 (R1) and reader 2
(R2) individual scores and combined average scores showedsignificant inverse correlation with E (R1, r ¼ e0.78, P ¼
.0001; R2, r ¼ e0.75, P ¼ .0003; average combined score
r ¼ e0.81, P ¼ .0001) (Figure 5). Bland and Altman plot
shows reasonable interobserver agreement with a mean
difference between scores of only 1.055 (Figure 6). Break-
down into anatomical region shows moderate strength of
agreement between readers in the majority, with agreement
being strongest in evaluation of the skull (Table 3).
Benign enostoses in the thoracic spine and iliac bone, and
the degenerative geode in the distal left femur were visual-
ized in all cases. Assessment of vertebral alignment and
degenerative disc disease in the lower lumbar spine was more
readily appreciable on MPRs. No features with regard to
image quality were more conspicuous on the sagittal or
coronal reformats. Average scores vs E showed several sets
of parameters with combined low dose and low Likert scores
(ie, adequate diagnostic quality). These were reassessed by
Figure 3. Sagittal multiplanar reformat of the spine on bone windows at the
chosen low-dose parameters of 140 kV, 14 mAs.
Table 2
Average Likert score vs anatomical location
Skull Thoracic spine Pelvis Femora
2 Reader average combined
scores (Likert scale)
1.81 2.52 2.64 1.84
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chosen for use in a clinical cohort (Figure 4). Optimum
parameters selected were the following: 140 kV, 14 mAs,
automated tube current modulation activated, and B60f
reconstruction algorithm.
Discussion
The scoring system used shows that whole-body low-dose
multidetector CT, at much lower doses than those previously
reported [7], can yield diagnostic quality images of normal
osseous structures. Doses equivalent to skeletal survey are
achievable, which makes low-dose CT a feasible alternative
to plain radiography for the assessment of patients with
plasma cell dyscrasias. It could be argued that, given the
superior accuracy of CT at detecting lytic myelomatous bone
lesions [4], whole-body low-dose CT technique should now
replace skeletal survey in clinical practice. Initial clinical
trials to assess sensitivity for detecting myelomatous lesions
of the lower-dose techniques described above have shown
encouraging results when compared with both skeletal
survey and whole-body MRI [11]. Issues regarding cost-
benefit analysis, accessibility to technology, and impact on
work practices and efficiency have yet to be fully elicited,
although a recent study reports that low-dose CT of the spine
can be more efficient than standard radiography in terms of
economizing work times of technicians [12].Statistical analysis of results showed a significant negative
correlation between the overall combined reader scores and
E, ie, low scores on the Likert scale (very good, good, or
average and/or diagnostic) show good correlation with
increasing dose, thus validating the scoring system used.
Interobserver agreement in various anatomical locations was
strongest in the skull, and overall average scores in each area
showed higher diagnostic quality in the skull and femora.
Reduced attenuation by soft tissues in these regions may
result in less noise and higher quality of images.
Several sets of parameters had both diagnostic quality
scores and a low effective dose. These were re-reviewed in
tandem, in a nonblinded fashion, in an effort to choose the
optimum set of parameters for use in a clinical cohort.
However, it was found that the differences between these
data sets were minimal, and a decision was made to choose
the set of values that was thought to be most robust in
a clinical setting. It is widely known that reducing the kVp or
mAs will lower the patient dose but will also increase noise
and reduce low-contrast detectability. However, given that
the organ and/or pathology of interest inherently exhibits
high subject contrast (bone vs soft tissue), noise should not
be such an important factor. It should be noted that, under
normal circumstances, noise is directly correlated with dose
(and the CTDI for each slice) as noise ¼ dosee½ and not the
effective dose. However, because the patient remained the
same for all scans, it allowed correlation to be made directly
with effective dose.
The effect of increasing the kVp in this series was note-
worthy. Typically, when the kVp is increased, the patient
exposure also increases. However, if the mAs can be reduced
significantly, then the CTDIvol values (and, therefore, patient
dose values) lower than the original will again be obtained.
When kVp is increased, subject contrast will decrease.
However, given that the mean energy of the CT beam is
about 60e70 keV and, given the greater number of electrons
per unit volume in bone, approximately 70%e75% of the
interactions in cortical bone could reasonably be attributed to
Compton interactions (the percentage in soft tissue being
approximately 90%e95%). Thus, one would not expect
a significant decrease in subject contrast when going from
100e120 kVp to 140 kVp. Also, at the higher kVp, x-ray
transmission is greater, and, therefore, absorption of energy
by the patient is decreased per incident exposure. Therefore,
it is not unreasonable to expect better photon statistics at the
detector (less noise) per radiation output produced at the
tube. The drawback of the higher kVp is the potential for
reduced subject contrast, however, this was not deemed to
grossly impact the diagnostic image quality as determined by
the reading radiologists. Therefore, because of variations in
Table 3
Kappa scores and interobserver agreement by anatomical location and image headings
Skull Thoracic spine Pelvis Femora
Trabecular pattern 0.55 (95% CI
0.2e0.89), P ¼ .004
0.45 (95% CI
0.16e0.76), P ¼ .002
0.53 (95% CI
0.22e0.84), P ¼ .001
0.52 (95% CI,
0.16e0.88), P ¼ .006
Cortical contours 0.55 (95% CI
0.2e0.89), P ¼ .004
0.43 (95% CI,
0.2e0.66), P ¼ .005
0.37 (95% CI,
0.08e0.67), P ¼ .003
0.34 (95% CI,
e0.08 to 0.76), P ¼ .000
Subjective image quality 0.45 (95% CI,
0.11e0.8), P ¼ .01
0.03 (95% CI,
e0.23 to 0.29), P ¼ .411
0.35 (95% CI,
0.0e0.6), P ¼ .007
0.33 (95% CI,
e0.05 to 0.72), P ¼ .000
Noise 0.62 (95% CI,
0.4e0.83), P ¼ .000
0.46 (95% CI,
0.18e0.74), P ¼ .002
0.56 (95% CI,
0.31e0.82), P ¼ .000
0.40 (95% CI,
0.07e0.72), P ¼ .005
Level of anatomical detail 0.31 (95% CI,
e0.05 to 0.66), P ¼ .06
0.30 (95% CI,
0.03e0.57), P ¼ .04
0.54 (95% CI,
0.22e0.86), P ¼ .000
0.30 (95% CI,
e0.02 to 0.61), P ¼ .024
CI ¼ confidence interval.
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preferred for use in a clinical cohort. It was thought that,
because of the inherent high contrast between bone and soft
tissues, a high kVp technique would prove less susceptible to
variations in body mass and abdominal girth. The compar-
ison of the effects of dose-reduction software on image
quality was assessed at 2 different parameter settings. Both
readers scores were only slightly lower with the use of dose-
reduction techniques, whereas effective doses showed
a significant drop. Reduction in overall dose was thought to
be more significant than the relatively minimal reduction in
image quality.
This study had several limitations. The use of a single
cadaver was a significant shortcoming. Ideally, cadavers of
various weights and abdominal girths would have been
imaged. Unfortunately, this was not feasible because of
ethics committee constraints and scanner accessibility. The
effects of varying body mass and girth on image quality was
thus not assessed.Eff Dose           = Effective Dose
_/_ (eg 100/80) = kVp/mAs setting
                         = Parameters chosen 
                             by consensus
no CD               = No CARE Dose
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Figure 4. Likert score versus effective dose, chosen set of exposure
parameters by consensus.Similarly, the use of a cadaver with myelomatous deposits
would have been useful to assess accuracy of the low-dose
technique in detecting pathologic lytic osseous lesions.
Cadavers with diffuse neoplastic processes are not routinely








































Figure 5. Average score of both readers individually and combined vs
effective dose (Eff Dose).
Figure 6. Bland and Altman plot of interobserver agreement.
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acquisition of a postmortem patient with proven myeloma
from the hospital. Despite this, the discrete lesions previ-
ously described, including a focal lytic, albeit benign,
degenerative cyst in the distal femur were shown to be
readily detectible in all cases. In addition, the ability of these
ultra-low-dose techniques to accurately assess normal
osseous structures is still of significant clinical relevance,
particularly given that these techniques would be used in the
assessment of patients with MGUS or smouldering myeloma,
both of which should not have any pathologic foci of
osteolysis.
It was also initially intended to assess details of soft
tissues in this study; however, extensive intravascular air and
thrombosis from the embalming process meant that the
majority of soft-tissue structures bore little resemblance to
their in vivo appearances, and, thus, analysis of diagnostic
quality in assessing these structures was not feasible. Simi-
larly, intravascular changes did not allow objective internal
measurements of noise by using region of interest and
standard deviation measurements in the abdominal aorta.
The primary objective of the study was to assess the
feasibility of various low-dose whole-body CT techniques
before use in a clinical cohort. The secondary intention of
choosing a single optimum technique to be used in a diverse
clinical cohort of patients with suspected or proven multiple
myeloma was ultimately achieved by consensus because
several sets of parameter combinations were deemed ofdiagnostic quality. The complex scoring system and statis-
tical analysis, therefore, served only to narrow the choices,
but no one set of parameters could be shown to have
a superior combination of diagnostic quality and low dose.
In conclusion, whole-body low-dose CT is technically
feasible, which allows the acquisition of images of sufficient
quality to assess normal osseous structures, at doses equiv-
alent to conventional radiographic skeletal survey.
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